Metabolic dysfunction-associated steatotic liver disease-associated fibrosis and cardiac dysfunction in patients with type 2 diabetes

Table 4 The bivariate correlations of the two liver fibrosis scores with echocardiographic parameters in type 2 diabetes mellitus patients with Metabolic dysfunction-associated steatotic liver disease

	FIB4, r (95%CI)	NFS, r (95%CI)
LV diastolic diameter	0.09 (-0.03; 0.22)	0.14 (0.02; 0.26)a
IV septum thickness	0.19 (0.07; 0.31)b	0.23 (0.11; 0.35)c
LV posterior wall thickness	0.12 (-0.004; 0.24)	0.18 (0.06; 0.30)b
Left atrium diameter	0.19 (0.07; 0.31)b	0.17 (0.04; 0.29)b
Right atrium diameter	0.17 (0.05; 0.29)b	0.21 (0.09; 0.32)d
Aortic annular diameter	0.13 (0.001; 0.25)a	0.09 (-0.04; 0.21)
EATT	0.12 (-0.004; 0.24)	0.13 (0.01; 0.25)a
LV end-systolic volume	0.08 (-0.05; 0.20)	0.14 (0.01; 0.26)a
LVMi	0.15 (0.02; 0.26)a	0.19 (0.06; 0.30)b
EF (%)	-0.13 (-0.25; -0.01)a	-0.21 (-0.33; -0.09)d
e’ septal	-0.24 (-0.36; -0.12)e	-0.19 (-0.31; -0.07)b
a’ septal	-0.13 (-0.25; -0.004)a	-0.10 (-0.22; 0.03)
e’/a’ septal	-0.14 (-0.27; -0.02)a	-0.12 (-0.24; 0.01)
E/e’ septal	0.19 (0.06; 0.31)b	0.19 (0.07; 0.31)b
Total LV segmental kinetics score	0.14 (0.01; 0.26)a	0.16 (0.04; 0.28)b

^aP < 0.05.

^bP < 0.01.

^cP = 0.0001.

^dP < 0.001.

^eP < 0.0001.

FIB4: Fibrosis-4; NFS: Non-alcoholic fatty liver disease-Fibrosis Score; 95%CI: 95% confidence interval; IV: Interventricular; LV: Left ventricle; EATT: Epicardial adipose tissue thickness; LVMi: Left ventricular mass index; EF: Ejection fraction.